Skip to main content
Clinical Trials/NCT01294137
NCT01294137CompletedNot Applicable

Accuracy of Pulse Oximetry to Detect Sleep Apnea in Frail Hospitalized Patients

AGIR à Dom2 sites in 1 country80 target enrollmentStarted: March 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80
Locations
2

Study Overview

Brief Summary

Sleep apnea syndrome is common and increases with age. In the elderly, symptoms might be different than in the youngest people, and its consequences might be severe and atypical (falls, functional and cognitive decline).

Today, there is no specific tool to detect sleep apnea in the elderly. The goal of this study is to evaluate the accuracy of oximetry for detection of respiratory disturbances in sleep apnea in the hospitalized elderly.

Detailed Description

Main goal: to define the more specific and sensitive cut-off of variability index of the oximetry to detect sleep apnea in the hospitalized elderly.

Secondary goals:

  • sleep apnea prevalence in the elderly
  • accuracy of other oximetry parameters (saturation line, oximetry desaturation index, autonomic arousals) for detection of respiratory disturbances in sleep apnea in the hospitalized elderly
  • to determine the clinical and biological data associated with sleep apnea in the hospitalized elderly
  • to determine the factors associated with the record failures and its prevalence
  • to study the prevalence of the Periodic Limb Movements of Sleep in the hospitalized elderly

Study design: simultaneous records by oximetry and ventilatory polygraphy with tibial EMG in the hospitalized elderly in a geriatric readaptation unit.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
75 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age > 75 ans
  • affiliation to the French health care system

Exclusion Criteria

  • hypoxemia with oxygenotherapy
  • already known and treated sleep apnea syndrome
  • mild to severe dementia (MMSE<18/30)
  • nocturnal neurpsychological disturbances
  • acute organic failure

Investigators

Sponsor
AGIR à Dom
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials